NYSE:GRDN (USA)
Â
Class A Shares
$
40.96
-0.10 (-0.24%)
11:08 PM EST
Business Description
Guardian Pharmacy Services Inc
NAICS : 623110
SIC : 5912
ISIN : US40145W1018
Share Class Description:
GRDN: Class A SharesTotal Employee Number:
3,600Description
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.76 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 0.36 | |||||
Interest Coverage | 119.22 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 12.49 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.3 | |||||
3-Year EBITDA Growth Rate | 10.8 | |||||
3-Year EPS without NRI Growth Rate | 22.5 | |||||
3-Year FCF Growth Rate | 34.7 | |||||
3-Year Book Growth Rate | 66.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 21.76 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.31 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.78 | |||||
9-Day RSI | 50.15 | |||||
14-Day RSI | 51.55 | |||||
3-1 Month Momentum % | 7.2 | |||||
6-1 Month Momentum % | 38.42 | |||||
12-1 Month Momentum % | 101.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.46 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 14.33 | |||||
Days Sales Outstanding | 25.62 | |||||
Days Payable | 35.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | 0.65 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 20.93 | |||||
Operating Margin % | 5.31 | |||||
Net Margin % | 3.65 | |||||
EBITDA Margin % | 7.03 | |||||
FCF Margin % | 4.81 | |||||
OCF Margin % | 6.1 | |||||
ROE % | 28.35 | |||||
ROA % | 13.82 | |||||
ROIC % | 22.35 | |||||
3-Year ROIIC % | -6.04 | |||||
ROC (Joel Greenblatt) % | 81.04 | |||||
ROCE % | 34.54 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 49.35 | |||||
Forward PE Ratio | 37.07 | |||||
PE Ratio without NRI | 35.93 | |||||
Price-to-Owner-Earnings | 47.24 | |||||
PS Ratio | 1.79 | |||||
PB Ratio | 11.74 | |||||
Price-to-Tangible-Book | 21.01 | |||||
Price-to-Free-Cash-Flow | 37.17 | |||||
Price-to-Operating-Cash-Flow | 29.3 | |||||
EV-to-EBIT | 32.52 | |||||
EV-to-Forward-EBIT | 25.59 | |||||
EV-to-EBITDA | 25.19 | |||||
EV-to-Forward-EBITDA | 20.69 | |||||
EV-to-Revenue | 1.77 | |||||
EV-to-Forward-Revenue | 1.81 | |||||
EV-to-FCF | 36.81 | |||||
Price-to-Graham-Number | 5.79 | |||||
| Price-to-Net-Current-Asset-Value | 89.04 | |||||
Earnings Yield (Greenblatt) % | 3.08 | |||||
FCF Yield % | 2.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:GRDN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guardian Pharmacy Services Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,455.972 | ||
| EPS (TTM) ($) | 0.83 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 27.6 | ||
| 14-Day RSI | 51.55 | ||
| 14-Day ATR ($) | 1.886979 | ||
| 20-Day SMA ($) | 41.404 | ||
| 12-1 Month Momentum % | 101.39 | ||
| 52-Week Range ($) | 19.295 - 44 | ||
| Shares Outstanding (Mil) | 63.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guardian Pharmacy Services Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guardian Pharmacy Services Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-10 16:30 | In 122 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 121 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-11 16:30 | In 31 days | ||
| Second quarter earnings results for 2026 | 2026-08-11 | In 30 days | ||
| Bank of America Healthcare Conference | 2026-05-13 09:20 | 34.91 (-2.32%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 16:30 | 37.24 (+1.25%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 37.24 (+1.25%) | ||
| General meeting for 2026 | 2026-05-05 13:00 | 36.64 (-1.48%) | ||
| Oppenheimer Healthcare MedTech & Services Conference | 2026-03-16 10:40 | 32.59 (-3.32%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-11 16:30 | 33.65 (+2.56%) |
Show
Entries
Guardian Pharmacy Services Inc Frequently Asked Questions
What is Guardian Pharmacy Services Inc(GRDN)'s stock price today?
The current price of GRDN is $40.96. The 52 week high of GRDN is $44.00 and 52 week low is $19.30.
When is next earnings date of Guardian Pharmacy Services Inc(GRDN)?
The next earnings date of Guardian Pharmacy Services Inc(GRDN) is 2026-08-11 Est..
Does Guardian Pharmacy Services Inc(GRDN) pay dividends? If so, how much?
Guardian Pharmacy Services Inc(GRDN) does not pay dividend.
Guru Commentaries on NYSE:GRDN
No articles.
Press Release
Articles on Guardian Pharmacy Services Inc
Headlines
See More- 1
Jun 22, 2026
Guardian Pharmacy announces COO and CFO succession
Seeking Alpha • 3:35pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers